loanDepot Faces NYSE Delisting Notice as Stock Trades Below $1

summarizeSummary

loanDepot received an NYSE delisting notice after its stock averaged below $1.00 for 30 trading days. The company has six months to cure the deficiency and may pursue a reverse stock split.

check_boxKey Events · Legal and Risk Events · LDI

• NYSE Delisting Notice Received

  On August 21, 2026, loanDepot received a deficiency letter from the NYSE because its Class A common stock averaged below $1.00 per share over a consecutive 30 trading-day period.

• Six-Month Cure Period

  The company has until approximately February 21, 2027 to regain compliance by achieving a closing price of at least $1.00 and a 30-day average of at least $1.00 on the last trading day of any calendar month.

• Reverse Stock Split Under Consideration

  Management will consider a reverse stock split to cure the deficiency, which would require stockholder approval at the next annual meeting anticipated for early June 2027.

• No Immediate Trading Impact

  The notice has no immediate impact on the listing or trading of loanDepot's common stock on the NYSE, subject to compliance with other continued listing requirements.

auto_awesomeAnalysis · LDI · Finance

A formal NYSE deficiency notice has been triggered after loanDepot's Class A common stock traded below $1.00 for 30 consecutive trading days. The company now has six months to regain compliance or face suspension and delisting. Management is weighing a reverse stock split, which would require shareholder approval at the next annual meeting in early June 2027. This is a critical governance and liquidity event for a company already under financial pressure, with cash dropping $108 million last quarter and equity at $333 million.